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Summary
Background Comprehensive tobacco control policies can help to protect children from tobacco smoke exposure and 
associated adverse respiratory health consequences. We investigated the impact of England’s 2015 regulation that 
prohibits smoking in a private vehicle with children present on changes in environmental tobacco smoke exposure 
and respiratory health in children.
Methods In this quasi-experimental study, we used repeated cross-sectional, nationally representative data from the 
Health Survey for England from Jan 1, 2008, to Dec 31, 2017, of children aged up to 15 years. We did interrupted time 
series logistic or ordinal regression analyses to assess changes in prevalence of self-reported respiratory conditions, 
prevalence of self-reported childhood tobacco smoke exposure (children aged 8–15 years only), and salivary cotinine 
levels (children aged 2 years or older) before and after implementation of the smoke-free private vehicle regulation on 
Oct 1, 2015. Children who were considered active smokers were excluded from the analyses of salivary cotinine levels. 
Our primary outcome of interest was self-reported current wheezing or asthma, defined as having medicines 
prescribed for these conditions. Analyses were adjusted for underlying time trends, quarter of year, sex, age, Index of 
Multiple Deprivation quintile, and urbanisation level.
Findings 21 096 children aged 0–15 years were included in our dataset. Implementation of the smoke-free private 
vehicle regulation was not associated with a demonstrable change in self-reported current wheezing or asthma 
(adjusted odds ratio 0·81, 95% CI 0·62–1·05; p=0·108; assessed in 13 369 children), respiratory conditions (1·02, 
0·80–1·29; p=0·892; assessed in 17 006 children), or respiratory conditions probably affecting stamina, breathing, 
or fatigue (0·75, 0·47–1·19; p=0·220; assessed in 12 386 children). Self-reported tobacco smoke exposure and 
salivary cotinine levels generally decreased over the study period. There was no additional change in self-reported 
tobacco smoke exposure in cars among children aged 8–15 years following the legislation (0·77, 0·51–1·17; 
p=0·222; assessed in 5399 children). We observed a relative increase in the odds of children having detectable 
salivary cotinine levels post legislation (1·36, 1·09–1·71; p=0·0074; assessed in 7858 children) and levels were also 
higher (1·30, 1·04–1·62; p=0·020; ordinal variable). Despite introduction of the regulation, one in 20 children still 
reported being regularly exposed to tobacco smoke in cars and one in three still had detectable salivary cotinine 
levels.
Interpretation We found no demonstrable association between the implementation of England’s smoke-free private 
vehicle regulation and changes in children’s self-reported tobacco smoke exposure or respiratory health. There is an 
urgent need to develop more effective approaches to protect children from tobacco smoke in various places, 
including in private vehicles.
Funding Netherlands Lung Foundation, Erasmus MC, Farr Institute, Health Data Research UK, Asthma UK Centre 
for Applied Research, Academy of Medical Sciences, and Newton Fund.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 
4.0 license.
Introduction
Environmental tobacco smoke exposure can pose a 
serious threat to children’s health. Among other adverse 
consequences, it increases the risk of developing asthma, 
having asthma attacks, and of respiratory tract infections.1–4 
An estimated 40% of all children around the world are 
regularly exposed to tobacco smoke, and children account 
for 28% of all deaths and 61% of all disability-adjusted life-
years caused by tobacco smoke exposure.5 Children who 
are exposed to tobacco smoke are also more likely to start 
smoking when they are older.6–8
Unlike adults, children usually cannot control their 
exposure to tobacco smoke. Tobacco control policies can 
help to protect children from tobacco smoke and its 
adverse health consequences. The implementation of 
compre hensive tobacco control policies, as recommended 
by WHO, has been shown to be associated with lower 
smoking prevalence, lower tobacco smoke exposure 
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among children and adults, and improvements in 
important child health outcomes.9–11 In particular, sub-
stantial evidence indicates that implementation of 
legislation to prohibit smoking in indoor public places 
and workplaces is associated with large improvements 
in important child health outcomes, including a 
10% decrease in hospital attendance for asthma and an 
18% decrease in hospital attendance for lower respiratory 
tract infections.10
Private vehicles are another important source of 
childhood tobacco smoke exposure. Smoking inside a car 
results in extremely high levels of toxins, even when the 
window is rolled down, and can also expose passengers 
to the potential health risks of third-hand smoke (ie, 
environmental contamination of surfaces by tobacco 
smoke constituents that remain after emission of tobacco 
smoke into the air).12–15
In 2015, England was one of the first nations in the 
world to implement a law prohibiting smoking in private 
vehicles when children are present.16 Although laws for 
smoke-free public spaces and workplaces have resulted 
in important improvements in childhood respiratory 
health,10 there is still little evidence on the health effects 
of smoke-free private vehicle legislation. We identified 
two North American studies, both describing a significant 
decline in self-reported childhood car tobacco smoke 
exposure after a smoke-free law was implemented.17,18 
One of the studies also found an association between the 
decrease in tobacco smoke exposure and self-reported 
asthma.18 Neither of the studies, however, involved 
biochemical validation of tobacco smoke exposure or 
evaluated the direct association between the smoke-free 
private vehicle laws and changes in respiratory health. 
Also, both studies assessed implementation of regu-
lations at the subnational level, and we are unaware of 
any evaluations of national smoke-free private vehicle 
regulations. We therefore aim to evaluate whether this 
novel policy strategy has been effective in reducing 
Research in context
Evidence before this study
Tobacco smoke exposure is the leading cause of preventable 
morbidity and premature mortality worldwide. Exposure 
during childhood increases the risk of asthma and respiratory 
tract infections. Children cannot control their tobacco smoke 
exposure and therefore need to be protected by tobacco 
control measures.
Our 2017 systematic review showed that legislation to prohibit 
smoking in indoor public places and workplaces was associated 
with substantial child health benefits. These included 
reductions of 4% in preterm births, 10% in hospital attendance 
for asthma, and 18% in hospital attendance for lower 
respiratory tract infections. Evidence indicates that these effects 
are probably mediated via reduced tobacco smoke exposure in 
public places, a decline in smoking during pregnancy, and, 
perhaps most importantly, reduced exposure at home.
Smoking in cars results in particularly high ambient air levels of 
toxic substances. Expanding national smoke-free legislation to 
include private vehicles could help to further protect children 
from tobacco smoke. On Oct 1, 2015, England and Wales were 
the first UK countries to introduce a national law that prohibits 
smoking inside private vehicles when children are present. 
Previous assessments of local smoke-free private vehicle laws in 
North America have shown significant reductions in self-
reported tobacco smoke exposure in cars among children after 
the law was implemented. However, no previous study has 
assessed the effect of a national smoke-free private vehicle law, 
or the effect of such regulations on biochemically validated 
tobacco smoke exposure and on respiratory health outcomes.
Added value of this study
In this quasi-experimental study, we assessed whether the 
introduction of the 2015 regulation in England was associated 
with changes in self-reported and biochemically validated 
tobacco smoke exposure and in respiratory health outcomes 
among children up to 15 years of age. To our knowledge, this is 
the first evaluation of a national legislation that prohibits 
smoking inside private vehicles with children present, and the 
first to assess its direct impact on respiratory health and 
biochemically validated tobacco smoke exposure. Children’s 
tobacco smoke exposure in cars showed an overall decrease 
over the study period. We did not, however, find a 
demonstrable effect of implementation of the regulation in 
England on children’s tobacco smoke exposure in cars or in 
other places and found no impact on respiratory health 
outcomes. Although salivary cotinine levels also decreased over 
the study period, indicating an overall reduction in tobacco 
smoke exposure, there was a relative increase post legislation. 
Despite introduction of the regulation, one in 20 children still 
reported being regularly exposed to tobacco smoke in cars and 
one in three children still had detectable salivary cotinine.
Implications of all the available evidence
Comprehensive smoke-free legislation covering enclosed public 
places is a powerful tool to protect children from the adverse 
health effects of tobacco smoke exposure. Whereas previous 
evaluations have shown smoke-free private vehicle laws at the 
local level to be associated with subsequent reductions in 
children’s tobacco smoke exposure, we were unable to confirm 
this in this first national evaluation. Substantial challenges have 
been reported in enforcement of the regulation in England, with 
very few fines or even warnings having been issued. Advocates 
argue that the primary goal of the regulation is to increase 
awareness and induce social norm changes. The substantial 
number of children remaining exposed despite introduction of 
the law, however, indicates that more effective approaches to 
protecting children’s health via reducing their tobacco smoke 
exposure in various places, including in cars, are needed.
Articles
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tobacco smoke exposure and improving child respiratory 
health in England.
Methods
Study design and setting
We did an interrupted time series analysis to determine 
whether the introduction of the national smoke-free 
private vehicle regulation in England on Oct 1, 2015, was 
associated with changes in salivary cotinine levels, self-
reported tobacco smoke exposure, and changes in 
prevalence of wheezing or asthma and of respiratory 
conditions overall. We used repeated cross-sectional data 
from the Health Survey for England (HSE),19 an annual 
survey of representative samples of English households 
aimed at identifying health and lifestyle trends of the 
English population. We used quarterly data spanning the 
period Jan 1, 2008, to Dec 31, 2017.
The UK Government enacted the smoke-free private 
vehicle regulation on Feb 12, 2015, and implemented the 
regulation on Oct 1, 2015, for England and Wales.16 From 
that date onwards, it has been prohibited in these UK 
jurisdictions to smoke inside private vehicles if a person 
under the age of 18 years is present in the vehicle. 
The driver and smokers who break this law risk a 
£50 (approximately US$60) fine each.20 Exceptions apply 
for convertible cars with the roof competely down and for 
e-cigarettes.
Ethical approval was not required for this study, as the 
data were already anonymised and publicly available. A 
detailed description of the HSE has been published 
elsewhere.21
Data sources
Each year since 1991, the HSE has taken an independent 
representative sample of the population living in private 
households in England, from here onwards referred to as 
the core sample, using a multistage stratified probability 
sampling design.22 In some years, an additional boost 
sample is collected to allow the study of a specific 
population subgroup, such as minority ethnic groups, 
older people, or children. In the years 2008, 2009, 2010, 
and 2015, an additional boost sample of children aged 
2–15 years was taken. In 2007, England implemented 
comprehensive national smoke-free legislation in 
workplaces and other enclosed public places; to avoid 
interference of this previous policy intervention with the 
more recent policy intervention, we only used data from 
2008 onwards.
All participating households received a home visit during 
which individual household members were interviewed 
about their general health, smoking, and alcohol use, and 
demographic, psychosocial, and socioeconomic indicators. 
In each household, up to four children were randomly 
selected to take part in the interview: up to two children 
aged 2–12 years and up to two children aged 13–15 years. 
In addition to the interviews, children aged 8–11 years and 
12–15 years were also asked to fill in a self-completion 
questionnaire enquiring about alcohol use, smoking, 
weight, and other topics not covered in the interviews, 
including their perceived environmental tobacco smoke 
exposure in various locations. Children and young adults 
who filled out the self-completion questionnaire were not 
interviewed again about the topics covered in this 
questionnaire. Adults aged 25 years or older did not fill out 
the questionnaire, but they were interviewed about their 
perceived tobacco smoke exposure and the other topics 
covered in the questionnaire.
Households in the core sample were offered an 
additional home visit from a nurse, who asked questions 
about prescribed medicines and took anthropometric 
measurements. With parental consent, the nurses also 
took saliva samples from participating children aged 
2 years or older to quantify cotinine levels. Cotinine is a 
metabolite of nicotine and is commonly used as a 
measure of tobacco smoke exposure. Salivary cotinine 
analyses were done by ABS Laboratories (Welwyn Garden 
City, Hertfordshire, UK). Cotinine concentrations were 
quantified using high-performance liquid chroma-
tography coupled to tandem mass spectrometry with 
multiple reaction monitoring.23 Participating households 
of the booster samples were not offered a nurse visit.
Outcomes
Our primary outcome of interest was self-reported 
current wheezing or asthma, defined as having pre-
scribed medicines for asthma or chronic obstructive pul-
monary disease (bronchodilators, inhaled cortico steroids, 
cromoglicate [ie, mast cell stabiliser] and related 
therapies, leukotriene receptor antagonists, phospho-
diesterase type-4 inhibitors, or supplemental oxygen). 
This outcome was assessed in respondents who had 
a nurse visit. Secondary outcomes were self-reported 
respiratory conditions (appendix p 1; unavailable in 
2010 and 2011 due to a technical routing error in the 
questionnaire24) and self-reported respiratory conditions 
probably affecting stamina, breathing, or fatigue 
(available from 2012 onwards). Secondary outcomes were 
assessed in the interview, and thus in all individuals 
surveyed. We had also intended to evaluate self-reported 
recent use of prescribed asthma medicines (ie, prescribed 
asthma medicines used in the week prior to the 
interview); however, these data were only available up 
until 2014, precluding investigation of its association 
with the 2015 legislation.
To explore the possible causal pathway between the 
introduction of the smoke-free private vehicle law and our 
outcomes of interest, we also determined the associations 
between the implementation of the smoke-free private 
vehicle law and the following intermediate variables: 
self-reported environ mental tobacco smoke exposure 
(categorised according to the following locations: in a car; 
at home; in the street; in other people’s homes; in outdoor 
areas of pubs, cafes, and restaurants; in parks or playing 
facilities; at school; or in any other public places) and 
See Online for appendix
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salivary cotinine levels (in the following categories: 
<0·1 ng/mL [ie, undetectable], 0·1–1·0 ng/mL, or 
>1·0 ng/mL). A salivary cotinine concentration of 
12·0 ng/mL or more was considered indicative of being an 
active smoker. Although HSE has released data on tobacco 
smoke exposure in cars since 2009, there was a substantial 
change in how these data were collected after 2010, 
resulting in an important trend break in self-reported 
tobacco smoke exposure in cars. To allow adequate 
comparisons over time, we therefore restricted our 
analyses of self-reported tobacco smoke exposure to the 
period 2011–17. Within each year, the HSE recorded the 
quarter of the year in which the interview was performed.
Statistical analysis
We did not have a pre-established sample size; there are 
no established methods for sample size calculations for 
time series analyses. Furthermore, our sample size was 
inherently limited to the number of HSE interviews 
conducted between 2008 and 2017 (the latter date 
representing the most recent available at the time of this 
study).
We tabulated key demographic variables, intermediate 
variables, and respiratory outcomes according to survey 
year. Using graphs, we also visually compared temporal 
trends in childhood tobacco smoke exposure in cars to 
childhood tobacco smoke exposure in other places.
We used interrupted time series logistic or ordinal 
regression analyses with adjustment for potential 
confounders to determine the associations between the 
introduction of the smoke-free private vehicle law and 
changes in the odds of developing each of the intermediate 
and respiratory outcome measures. Appropriate selection 
and non-response weights were used in each model, as 
recommended and provided for by HSE.25 The models 
took into account the underlying temporal trend in odds 
of developing each outcome, and provided an estimate of 
either the immediate (step) change or gradual (slope) 
change, or both, after the introduction of the smoke-free 
private vehicle law. To account for possible non-linearity, 
the underlying temporal trend was modelled via linear, 
quadratic, and cubic B-splines in separate models. The 
optimal model was then selected using the Akaike 
information criterion and Schwarz’s Bayesian infor-
mation criterion. The step change for the odds of 
developing each outcome was modelled using a dummy 
variable for the intervention coded 0 before the 
introduction of the law (ie, up to and including the third 
quarter of 2015) and 1 after the introduction of the law 
(from the fourth quarter of 2015). The slope change was 
modelled using an interaction term of the step change 
dummy variable and time in quarters (as a continuous 
variable). A categorical variable for quarter of the year was 
added to account for seasonality. Due to missing data for 
respiratory con ditions in 2010 and 2011, we modelled 
time categorically (in quarters) instead of continuously in 
the analysis of respiratory conditions. For this analysis, 
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we were therefore unable to model whether the smoke-
free private vehicle law was associated with a slope change 
and thus included a step change only. Accounting for 
autocorrelation was not required as we used individual-
level data.
We adjusted for the following potential individual-level 
confounders: age category (0–4 years, 5–7 years, 8–12 years, 
or 13–15 years), sex, socioeconomic status based on 
the Index of Multiple Deprivation in quintiles,26 and 
urbanisation level (urban or rural [ie, town, fringe, village, 
hamlet, and isolated dwellings]). Analyses of self-reported 
tobacco smoke exposure were not adjusted for the first two 
age categories (0–4 years and 5–7 years), as these data were 
collected only among children aged 8–15 years. Children 
who were considered active smokers (ie, children who 
reported they smoked regularly or used other nicotine-
delivery products including e-cigarettes, or who had a 
salivary cotinine concentration ≥12·0 ng/mL) were 
excluded from the analyses of cotinine levels, but not of 
the other outcomes. Cotinine was analysed in separate 
analyses as an ordinal (<0·1 ng/mL, 0·1–1·0 ng/mL, or 
>1·0 ng/mL) or binary (<0·1 ng/mL vs ≥0·1 ng/mL) 
variable. Because household identifiers were no longer 
collected after 2014, we were unable to account for 
clustering of children at the household level.
For our main analyses, we used the core samples of the 
HSE only. The HSE included additional booster samples 
of children in 2008, 2009, 2010, and 2015. The households 
in these booster samples were selected from the same 
sampling units as the core samples. Generally, HSE does 
not recommend combining the two sample types for the 
main analyses because the combined sample is not 
designed to be generalisable to the English population.25 
However, as it increases the sample size and, as such, the 
power to detect relevant changes, we did sensitivity 
analyses of our health outcomes combining the core and 
booster samples.
The HSE questionnaire allows for more than one 
chronic condition to be registered, and the released 
datasets do not specify which of these chronic conditions 
affect stamina, breathing, or fatigue. Although unlikely, 
for children with both a respiratory condition and 
another chronic condition, it is possible that only the 
non-respiratory condition affected stamina, breathing, or 
fatigue. In a sensitivity analysis, we therefore repeated 
the analysis of respiratory conditions affecting stamina, 
breathing, or fatigue including only those children who 
registered a respiratory condition but no other chronic 
condition.
By means of validation, we also explored patterns of 
adult environmental tobacco smoke exposure to compare 
changes in adult and child self-reported tobacco smoke 
exposure in various locations.
All analyses were done using Stata SE 15.1. We used 
the STROBE and RECORD guidelines to report our 
findings.27,28
Role of the funding source
The funders of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had final 
responsibility for the decision to submit for publication.
Results
Between Jan 1, 2008, and Dec 31, 2017, 21 096 children 
aged 0–15 years were interviewed in the HSE core 
samples. Of these, 5400 children aged 8–15 years reported 
on their environmental tobacco smoke exposure. In total, 
13 371 children aged 0–15 years had a nurse visit and 
7999 children aged 2–15 years had their salivary cotinine 
concentration determined, 7860 of whom were included 
in the analysis. The additional booster samples consisted 
of 4048 children aged 0–15 years in 2008, 2810 children 
in 2009, 3618 children in 2010, and 3591 children in 2015. 
The demographic characteristics of the core samples 
were similar between the annual samples (table 1).
Across the study period, 969 (7·2%) of 13 371 children 
reported having current wheezing or asthma (table 2). 
998 (5·9%) of 17 008 children reported a respiratory 
2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 Total
Primary outcome
Current wheezing or asthma 173/2464 
(7·0%)
51/807 
(6·3%)
114/1327 
(8·6%)
84/1257 
(6·7%)
108/1203 
(9·0%)
106/1455 
(7·3%)
78/1249 
(6·2%)
103/1297 
(7·9%)
73/1117 
(6·5%)
79/1195 
(6·6%)
969/13 371 
(7·2%)
Secondary outcomes
Self-reported respiratory 
condition
256/3473 
(7·4%)
82/1147 
(7·1%)
·· ·· 120/2042 
(5·9%)
105/2182 
(4·8%)
108/2003 
(5·4%)
118/2123 
(5·6%)
107/2054 
(5·2%)
102/1984 
(5·1%)
998/17 008 
(5·9%)
Missing data 0 0 ·· ·· 1 3 0 0 2 1 7
Self-reported respiratory 
condition affecting stamina, 
breathing, or fatigue
·· ·· ·· ·· 69/2042 
(3·4%)
71/2182 
(3·3%)
75/2003 
(3·7%)
76/2123 
(3·6%)
75/2054 
(3·7%)
61/1984 
(3·1%)
427/12 388 
(3·4%)
Missing data ·· ·· ·· ·· 1 3 0 0 2 1 7
The primary outcome is measured on all individuals who had a nurse visit; there were no missing values among these individuals. The secondary outcomes are measured on all surveyed individuals. Percentages 
are calculated on all individuals surveyed for a given outcome with non-missing values. Empty cells indicate that data were unavailable for that survey year. 
Table 2: Primary and secondary outcomes by survey year
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condition, with 427 (3·4%) of 12 388 children noting that 
their chronic condition affected stamina, breathing, or 
fatigue (table 2). There was no clear temporal trend in 
wheezing or asthma (figure), a slight decreasing trend in 
respiratory conditions overall, and a slight increasing 
trend in respiratory conditions probably affecting 
stamina, breathing, or fatigue (table 2; appendix p 2). Self-
reported tobacco smoke exposure in a car decreased over 
the study period (figure), with varying temporal trends for 
exposure in other places (table 3; appendix pp 3–4).
A model with a step change only was the optimal model 
for each of the outcomes. In our primary analyses, 
introduction of the smoke-free private vehicle law was 
not associated with significant changes in the prevalence 
of current wheezing or asthma (adjusted odds ratio 
[aOR] 0·81, 95% CI 0·62–1·05), self-reported respiratory 
conditions (1·02, 0·80–1·29), or self-reported respiratory 
conditions probably affecting stamina, breathing, or 
fatigue (0·75, 0·47–1·19; table 4). Similarly, we did not 
observe significant changes after introduction of the law 
in the prevalence of self-reported tobacco smoke exposure 
(table 5). Although salivary cotinine levels generally 
decreased over the study period (appendix p 4), there was 
a relative increase in the odds of having detectable 
salivary cotinine post-legislation, and these levels were 
also higher after the smoke-free private vehicle regulation 
(table 5).
When including data from the booster samples in 
sensitivity analyses, we also did not observe significant 
changes in the prevalence of self-reported respiratory 
conditions (aOR 1·02, 95% CI 0·83–1·26), self-reported 
respiratory conditions probably affecting stamina, 
breathing, or fatigue (0·76, 0·54–1·09), and self-reported 
tobacco smoke exposure in a car (0·88, 0·62–1·24; 
appendix pp 5–6). When limiting the analysis to the 
12 386 children who only reported a respiratory condition 
and no other chronic illnesses, we also did not observe a 
significant change in the prevalence of self-reported 
respiratory conditions affecting stamina, breathing, 
or fatigue (0·59, 0·34–1·03; appendix p 7).
By means of validation, we related the observed patterns 
in paediatric tobacco smoke exposure to reported 
exposure and smoking patterns among adults. Imple-
mentation of the smoke-free private vehicle regulation 
was not associated with significant changes in active 
smoking or tobacco smoke exposure in cars among adults 
(appendix pp 8–15). However, implementation of the 
smoke-free private vehicle regulation was associated with 
an increase in smoking at home for smokers older than 
24 years of age but a decrease in smoking in other people’s 
homes for smokers aged 16–24 years (appendix pp 11, 15).
Discussion
In this national study using data representative of the 
English population, implementation of a regulation 
prohibiting smoking in cars with children present was 
not associated with demonstrable improvements in 
asthma outcomes, in self-reported chronic respiratory 
diseases, or self-reported tobacco smoke exposure in cars 
among children.
There is compelling evidence from various countries 
including England that implementation of compre hensive 
legislation prohibiting smoking in enclosed public places 
is associated with improved respiratory health among 
children, particularly improve ments in asthma exacer-
bations and lower respiratory tract infections necessitating 
hospital attendance.10,29–31 When considering the negative 
findings of the current study, it is important to note that 
the smoke-free private vehicle regulation was introduced 
in a setting of existing comprehensive smoke-free 
legislation in England. Evidence from England and 
elsewhere indicates that smoke-free legislation, in addition 
to protecting children from tobacco smoke exposure in 
public places, also induces social norm changes resulting 
in many families making their own homes and cars smoke 
free.32–35 It is possible that such norm changes also 
contributed to the observed gradual decrease in smoking 
in cars with children present in the period before the 
smoke-free private vehicle law came into force.36
Although there was a clear reduction in children’s 
tobacco smoke exposure in cars over the study period, we 
Figure: Prevalence over time of current wheezing or asthma and of self-
reported tobacco smoke exposure in a car
(A) Prevalence of current wheezing or asthma. (B) Prevalence of self-reported 
tobacco smoke exposure in a car.
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could not definitely attribute this to implementation of 
the smoke-free private vehicle law. While the 95% CI was 
wide, thus preventing definite conclusions, the point 
estimate indicates that a relative reduction of 23% in self-
reported exposure in cars might have occurred. This 
figure corresponds well with earlier studies that did show 
significant findings. In a difference-in-difference analysis 
comparing Canadian regions according to whether they 
had implemented smoke-free private vehicle regulations, 
such laws were associated with a 26% relative reduction 
in tobacco smoke exposure among 10–17-year olds.17 In 
California, self-reported tobacco smoke exposure in cars 
among school-age children diminished by 13% per year 
after implementation of a state-wide smoke-free private 
vehicle law.18 Of concern, however, our study shows 
that 6% of all children surveyed in the year following 
implementation of the English smoke-free private vehicle 
law were still regularly exposed to tobacco smoke in cars, 
compared with 9% in the previous year. These figures 
clearly indicate that compliance with the smoke-free law 
was weak and they are in stark contrast with the excellent 
compliance with England’s 2007 smoke-free law in 
enclosed public places and workplaces; in the year 
following this law’s introduction, more than 98% of 
public places were found to be compliant.37
For obvious reasons, enforcement of a regulation that 
prohibits smoking in a private vehicle when children are 
present is challenging. Prior to implementation of the 
smoke-free private vehicle law in England, police 
spokesmen announced that the police force was not 
planning to actively enforce the law or issue fines to 
violators.38,39 This argument appears to have been 
embedded within a broader message relating to the 
planned financial cuts regarding police forces at the time. 
Freedom of Information responses from 42 English and 
Welsh police forces indeed indicated that only one fine 
and almost no warnings were issued in the first 7 months 
after the law’s introduction.40 At the time of introduction, 
supporters of the law argued that its predominant 
anticipated impact would be to induce social norm 
changes regarding smoking in the presence of children. 
While previous studies have indicated that such norm 
changes occurred after legislation prohibiting smoking in 
enclosed public places,33,36,41–47 our study fails to provide 
evidence that the smoke-free private vehicle regulation 
resulted in children being less exposed to tobacco smoke; 
in fact, cotinine levels indicated that overall exposure 
increased over and above the underlying decreasing 
temporal trend. At the same time, adult smokers more 
often reported having smoked in or around their homes, 
although this was not accompanied by a significant 
increase in children’s self-reported tobacco smoke 
exposure at home in our primary analyses. Whether 
displacement of smoking from cars to homes might in 
fact be an issue therefore warrants further study.
Children have the right to grow up smoke free, and 
protecting children from the harms associated with 
tobacco smoke exposure is essential.48 Air concentrations 
of toxic substances upon smoking in a car easily exceed 
levels typically observed in smoky bars.49 Public support for 
smoke-free private vehicle regulations is widespread. In 
England, 87% of all adults, including 76% of all smokers, 
supported such regulations in 2016, and these numbers 
were higher than in a comparable survey done before the 
law was implemented.50 We believe that lack of enforcement 
is the most likely explanation for the weak compliance 
with the smoke-free private vehicle regulation as shown 
in our study. This indicates that additional measures 
are necessary to address challenges in enforcement of 
such regulations and accordingly enhance compliance.40 
Before implementing similar laws in other countries, 
policy makers should align with the various stakeholders, 
including the parties responsible for enforcement, to 
ensure that unambiguous and consistent messages are 
communicated towards the public and that realistic 
and sustainable plans for enforcement are in place. Media 
campaigns should precede and accompany imple-
mentation, clearly referring to the substantial health 
benefits of protecting children from tobacco smoke. 
Total sample Direct change in outcome after 
smoke-free car regulation
Adjusted odds 
ratio (95% CI)
p value
Tobacco smoke exposure*
In a car 5399 0·77 (0·51–1·17) 0·222
At home 5399 1·17 (0·83–1·64) 0·369
In other people’s homes 5399 0·93 (0·70–1·24) 0·630
Salivary cotinine†
Cotinine level (ordinal: <0·1, 0·1–0·9, ≥1·0 ng/mL) 7858 1·30 (1·04–1·62) 0·020
Detectable cotinine (≥0·1 ng/mL) 7858 1·36 (1·09–1·71) 0·0074
Reported changes are step changes. All analyses were adjusted for linear time trends, quarter of year, sex, age, Index of 
Multiple Deprivation quintile, and level of urbanisation. Only cases with no missing variables were included. *Tobacco 
smoke exposure is measured in children aged 8–15 years. †Non-smoking children or children with salivary cotinine 
concentration <12 ng/mL only.
Table 5: Associations between the smoke-free private vehicle regulation and intermediate outcomes
Total sample Direct change in outcome after 
smoke-free car regulation
Adjusted odds 
ratio (95% CI)
p value
Primary outcome
Current wheezing or asthma 13 369 0·81 (0·62–1·05) 0·108
Secondary outcomes
Self-reported respiratory condition* 17 006 1·02 (0·80–1·29) 0·892
Self-reported respiratory condition probably 
affecting stamina, breathing, or fatigue
12 386 0·75 (0·47–1·19) 0·220
Reported changes are step changes. All analyses were adjusted for underlying time trends, quarter of year, sex, age, 
Index of Multiple Deprivation quintile, and level of urbanisation. Only cases with no missing variables were included. 
*The analysis of self-reported respiratory conditions included time in years as a categorical variable because outcome 
data were unavailable for years 2010 and 2011.
Table 4: Associations between the smoke-free car regulation and primary and secondary outcomes
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Regulatory aspects of a law aimed at protecting children 
from tobacco smoke exposure in cars should also be 
considered. For example, a law prohibiting smoking in 
private vehicles might be easier to regulate if smoking is 
prohibited irrespective of whether children are present. In 
a 2016 survey among adults in England, 62% supported 
such an extension of the law.50 Here, we showed that in the 
years following the English smoke-free private vehicle law, 
one in five adult smokers had still smoked in a car during 
the previous week. The fact that smoking in a car has in 
itself been associated with being involved in a traffic 
accident could provide another argument for regulating 
smoking in private vehicles more generally.51 Such a 
comprehensive smoke-free private vehicle law might also 
help to reduce exposure of children (and other passengers) 
to the potential dangers of third-hand smoke lingering in 
the car after the cigarette is extinguished.52 Last, given that 
vaping in a car can still expose children to nicotine and 
perhaps other harmful substances, the current exception 
of vaping from the smoke-free private vehicle regulation 
might require revisiting.53
It is essential that policy makers continue to explore 
opportunities for introducing effective measures to 
protect children from tobacco smoke exposure and that 
the effectiveness of such regulations is assessed via 
robust policy evaluations. Such evaluations have clearly 
shown that legislation prohibiting smoking in public 
places effectively reduces child tobacco smoke exposure 
and, through doing so, substantially benefits child 
health.10 Whereas earlier studies have indicated that 
smoke-free private vehicle regulations might also be 
effective in reducing children’s exposure to tobacco 
smoke,17,18 we were unable to replicate this finding in 
England, observing no demonstrable health benefits in 
the children surveyed; this lack of effect was probably 
owing to little compliance and enforcement of the 
regulation. Additional studies in, and perhaps across, 
other countries are needed to further evaluate the 
effectiveness of smoke-free private vehicle regulations 
and to explore the regulatory aspects determining 
effectiveness.
To our knowledge, this is the first study to have evaluated 
the direct association between the introduction of a 
smoke-free private vehicle law and changes in childhood 
respiratory diseases. It is also unique in its evaluation of a 
smoke-free private vehicle law implemented nationally. 
Unlike earlier studies assessing subnational regulations, 
we included both subjective and objective measures of 
tobacco smoke exposure among children in our evaluation. 
We made use of weighted survey data from HSE, which 
contained timely data for a substantial number of children, 
including both self-reported and biochemically validated 
data, and was designed to be representative of the entire 
population of England. The use of individual-level data 
allowed us to account for several potential confounders, 
thus addressing a key drawback of population-level (ie, 
aggregated) interrupted time series analyses. The nature 
of HSE data also provided us with much more granular 
data over time (ie, quarterly vs biennially or annually), 
allowing us to more reliably estimate and account for 
temporal trends.
Our study has some potential limitations. National 
policy interventions are typically not implemented in a 
randomised fashion, and although we used a robust quasi-
experimental design considered optimal for evaluating 
such interventions, the observational nature of our study 
and the lack of a control group inherently limit causal 
inference.54 We sought to at least partly address this by 
accounting for important known and available con-
founding factors. Relying on data that were collected by 
the HSE, our sample size was inherently limited to the 
number of children surveyed, individual children could 
not be followed up, and the post-intervention observation 
period was relatively short. Additionally, we were limited 
by missing datapoints and temporal changes in definitions 
for a number of variables. Finally, from HSE data, it is not 
possible to discern whether self-reported tobacco smoke 
exposure might partly include exposure to vaping, 
although any effect on our findings is likely to be small.55
In conclusion, although children’s environmental 
exposure to tobacco smoke in cars has been decreasing 
in England over the past 10 years, we found no additional 
reductions in children’s tobacco smoke exposure in cars 
or prevalence of asthma or respiratory health problems 
following implementation of England’s 2015 national 
legislation prohibiting smoking in private vehicles 
when children are present. Stricter enforcement might 
be required to improve compliance, which seems much 
weaker than with the 2007 legislation prohibiting 
smoking in enclosed public places. There is an urgent 
need to investigate more effective approaches to 
protecting children from tobacco smoke in cars and 
elsewhere.
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